US4190659A
(en)
*
|
1973-08-27 |
1980-02-26 |
Sandoz, Inc. |
Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
|
US4281131A
(en)
|
1977-06-20 |
1981-07-28 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
US4187309A
(en)
*
|
1977-06-20 |
1980-02-05 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
US4273930A
(en)
*
|
1977-06-20 |
1981-06-16 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acid esters
|
US4221797A
(en)
*
|
1978-08-14 |
1980-09-09 |
Sandoz, Inc. |
Dihydroquinoline-one derivatives
|
FR2443467A1
(fr)
*
|
1978-12-08 |
1980-07-04 |
Roussel Uclaf |
Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
|
FR2482596A1
(fr)
*
|
1980-05-19 |
1981-11-20 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
|
US4266050A
(en)
*
|
1980-07-02 |
1981-05-05 |
American Home Products Corporation |
1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
|
IE52670B1
(en)
*
|
1981-03-03 |
1988-01-20 |
Leo Ab |
Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
|
FR2523130A1
(fr)
*
|
1982-03-15 |
1983-09-16 |
Roussel Uclaf |
Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
FR2507602A1
(fr)
*
|
1981-06-12 |
1982-12-17 |
Roussel Uclaf |
Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
HU190796B
(en)
*
|
1981-06-12 |
1986-11-28 |
Roussel Uclaf,Fr |
Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
|
FR2509728A1
(fr)
*
|
1981-07-17 |
1983-01-21 |
Roussel Uclaf |
Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
FR2537139B2
(fr)
*
|
1982-03-15 |
1985-09-20 |
Roussel Uclaf |
Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
|
FR2551437B2
(fr)
*
|
1982-06-03 |
1985-10-25 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
|
FR2530633A1
(fr)
*
|
1982-06-03 |
1984-01-27 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
|
FR2532939A1
(fr)
*
|
1982-09-13 |
1984-03-16 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
|
FR2537140B1
(fr)
*
|
1982-12-07 |
1986-07-18 |
Roussel Uclaf |
Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
|
SE452170B
(sv)
*
|
1983-10-03 |
1987-11-16 |
Boliden Ab |
Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
|
FR2566405B1
(fr)
*
|
1984-06-25 |
1986-09-26 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
|
US4602014A
(en)
*
|
1984-07-09 |
1986-07-22 |
Ciba-Geigy Corporation |
Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
|
JPH0358559A
(ja)
*
|
1989-07-26 |
1991-03-13 |
Sekisui Chem Co Ltd |
電話システム
|
US5175151A
(en)
*
|
1990-09-07 |
1992-12-29 |
Schering Corporation |
Antiviral compounds and antihypertensive compounds
|
US5412104A
(en)
*
|
1990-09-07 |
1995-05-02 |
Schering Corporation |
Ester and alkoxy substituted benzopyrans
|
US5179093A
(en)
*
|
1991-05-10 |
1993-01-12 |
Schering Corporation |
Quinoline-diones
|
DE4138820A1
(de)
*
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
SE9201076L
(sv)
*
|
1992-04-06 |
1993-10-07 |
Shimon Slavin |
Användningen av gamla läkemedel för behandling av diabetes
|
SE9400810D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of Quinoline-3-carboxamide compounds
|
SE9400809D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of quinoline-3-carboxamide compounds
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
US8314124B2
(en)
|
2004-02-06 |
2012-11-20 |
Active Biotech Ab |
Crystalline salts of quinoline compounds and methods for preparing them
|
SE0400235D0
(sv)
*
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
RU2528046C2
(ru)
*
|
2004-06-24 |
2014-09-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы транспортеров атф-связывающей кассеты
|
PL1773816T3
(pl)
|
2004-06-24 |
2015-06-30 |
Vertex Pharma |
Modulatory transporterów posiadających kasetę wiążącą ATP
|
WO2006087830A1
(ja)
*
|
2005-02-18 |
2006-08-24 |
Kanebo, Ltd. |
帯状織物構造体およびその製法
|
RS53666B1
(en)
*
|
2005-10-19 |
2015-04-30 |
Teva Pharmaceutical Industries Ltd |
CRYSTALS OF SODIUM LAKVINIMOD AND THE PROCESS FOR OBTAINING THEM
|
JP2009521468A
(ja)
*
|
2005-12-24 |
2009-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Abc輸送体の調節因子としてのキノリン−4−オン誘導体
|
HUE049976T2
(hu)
*
|
2005-12-28 |
2020-11-30 |
Vertex Pharma |
N-[2,4-bisz(1,1-dimetil-etil)-5-hidroxi-fenil]-1,4-dihidro-4-oxo-kinolin-3-karboxamid amorf alakjának gyógyászati kompozíciói
|
DK2035001T3
(da)
|
2006-06-12 |
2012-02-27 |
Teva Pharma |
Stabile laquinimod-tilberedninger
|
WO2008097976A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
SI2234485T1
(sl)
*
|
2007-12-20 |
2014-03-31 |
Teva Pharmaceutical Industries Ltd. |
Stabilni lakvinimodni pripravki
|
WO2010028015A2
(en)
*
|
2008-09-03 |
2010-03-11 |
Auspex Pharmaceuticals, Inc |
2-oxo-1,2-dihydro-quinoline modulators of immune function
|
KR101852173B1
(ko)
|
2009-03-20 |
2018-04-27 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정자의 제조 방법
|
JP5882208B2
(ja)
*
|
2009-07-30 |
2016-03-09 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラキニモドによるクローン病の治療
|
AU2010282948C1
(en)
*
|
2009-08-10 |
2017-03-02 |
Active Biotech, Ab |
Treatment of BDNF-related disorders using laquinimod
|
SG183513A1
(en)
*
|
2010-03-03 |
2012-09-27 |
Teva Pharma |
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
|
ES2601819T3
(es)
*
|
2010-03-03 |
2017-02-16 |
Teva Pharmaceutical Industries Ltd. |
Tratamiento de la artritis lúpica usando laquinimod
|
MX337614B
(es)
*
|
2010-03-03 |
2016-03-10 |
Teva Pharma |
Tratamiento de lupus nefritis usando laquinimod.
|
CN102267984B
(zh)
*
|
2010-06-04 |
2014-07-30 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
|
BR112013007850A2
(pt)
|
2010-10-14 |
2016-06-07 |
Immunahr Ab |
1,2-diidro-4-hidróxi-2-oxo-quinolina-3-carboxanilidas como ativadores de ahr
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
EP2537517A1
(en)
*
|
2011-06-22 |
2012-12-26 |
Active Biotech AB |
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
|
EP2766020A4
(en)
|
2011-10-12 |
2015-04-01 |
Teva Pharma |
TREATMENT OF MULTIPLE SCLEROSIS BY COMBINING LAQUINIMOD AND FINGOLIMOD
|
SG11201404214QA
(en)
|
2012-02-03 |
2014-08-28 |
Teva Pharma |
USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY
|
BR112014021090B1
(pt)
|
2012-02-27 |
2023-01-24 |
Vertex Pharmaceuticals Incorporated |
Composição farmacêutica e uso de n-[2,4-bis(1,1-dimetiletil)-5-hidróxifenil]-1,4-di-hidro-4-oxoquinolina3-carboxamida na preparação da mesma
|
TW201400117A
(zh)
|
2012-06-05 |
2014-01-01 |
Teva Pharma |
使用拉喹莫德治療眼發炎疾病
|
CA2890194A1
(en)
|
2012-11-07 |
2014-05-15 |
Teva Pharmaceutical Industries Ltd. |
Amine salts of laquinimod
|
EP2951168B1
(en)
|
2013-01-31 |
2017-01-04 |
Vertex Pharmaceuticals Incorporated |
Quinoline and quinoxaline amides as modulators of sodium channels
|
US20160046582A1
(en)
|
2013-03-14 |
2016-02-18 |
Teva Pharmaceutical Industries Ltd. |
Crystals of laquinimod sodium and improved process for the manufacture thereof
|
SG11201608674UA
(en)
|
2014-04-29 |
2016-11-29 |
Teva Pharma |
Laquinimod for the treatment of relapsing-remitting multiple sclerosis (rrms) patients with a high disability status
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|